Ceftriaxone And Dextrose Injection, Solution
Product Images NDC 0264-3153

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ceftriaxone And Dextrose (NDC 0264-3153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Ceftriaxone And Dextrose In Duplex 1)

An instructional diagram labeled 'Diagram 1' showing a folding or opening step of packaging with a visible side tab. The image likely demonstrates how to access or prepare the product inside the packaging but contains no specific product text or identifiers.*

FDA Label Image

2g 50_ml Container Label 3155-11 (Ceftriaxone And Dextrose In Duplex 10)

Label for CefTRIaxONE for Injection and Dextrose Injection, 2 g per 50 mL solution, intravenous injection. The label includes detailed reconstitution instructions, storage conditions, and dosing information. It is a single-dose, sterile, iso-osmotic solution packaged in a duplex container by B. Braun Medical Inc., Bethlehem, PA.*

FDA Label Image

Drug Chamber Label (Ceftriaxone And Dextrose In Duplex 11)

A text panel titled Drug Chamber with instructions to discard the unit if the foil strip is damaged and to peel the foil strip only when ready for use. It advises visual inspection of the drug prior to reconstitution and refers to the package insert for complete directions for reconstitution and administration.*

FDA Label Image

Diagram 2 (Ceftriaxone And Dextrose In Duplex 2)

Illustration showing the layout of a CEFTRIAXONE AND DEXTROSE injection solution dual-chamber container. It labels the diluent chamber, drug powder chamber with a peel strip, hanger tab, and set port with foil cover, indicating how the drug powder and diluent are separated before reconstitution and intravenous administration.*

FDA Label Image

Diagram 3 (Ceftriaxone And Dextrose In Duplex 3)

An instructional line drawing showing hands pressing on the edges of a rectangular container or device, with an arrow indicating movement, suggesting a step in the use or activation of a medical injection device or solution container. The illustration highlights how to manipulate the container, possibly for mixing or preparing the intravenous injection solution.*

FDA Label Image

Diagram 4 (Ceftriaxone And Dextrose In Duplex 4)

An instructional line drawing labeled Diagram 4 showing hands holding a medical device or vial adaptor. The illustration appears to demonstrate a step in the preparation or administration process for an intravenous injection, likely related to the CEFTRIAXONE AND DEXTROSE injection solution.*

FDA Label Image

Diagram 5 (Ceftriaxone And Dextrose In Duplex 5)

An instructional diagram showing a solution bag with a set port at the bottom, covered by a foil cover. The diagram is labeled as Diagram 5 and illustrates the location and structure of these components on the bag.*

FDA Label Image

Ceftriaxone Molecular Formula (Ceftriaxone And Dextrose In Duplex 6)

Chemical structure of ceftriaxone, the active ingredient in CEFTRIAXONE AND DEXTROSE injection solution. The diagram shows the molecular arrangement including sodium salt forms and associated water molecules.*

FDA Label Image

Dextrose Molecular Formula (Ceftriaxone And Dextrose In Duplex 7)

Chemical structure diagram showing a molecular representation with hydroxyl groups, oxygen atoms, and a side chain ending in OH and water (H2O) molecules. This likely represents the chemical structure of dextrose as related to the product CEFTRIAXONE AND DEXTROSE.*

FDA Label Image

1g 50_ml Container Label 3153-11 (Ceftriaxone And Dextrose In Duplex 8)

Label for Ceftriaxone and Dextrose Injection 1 g/50 mL intravenous solution in a Duplex container by B. Braun Medical Inc. The label includes directions for reconstitution, storage instructions, content information, and manufacturer details. The NDC number and barcode are visible at the bottom.*

FDA Label Image

Drug Chamber Label (Ceftriaxone And Dextrose In Duplex 9)

A drug chamber instruction panel for CEFTRIAXONE AND DEXTROSE injection solution. It advises discarding the unit if the foil strip is damaged, peeling the foil only when ready for use, visually inspecting the drug before reconstitution, and refers to the package insert for detailed reconstitution and administration directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.